Oscar Health, Inc. (OSCR) Advances While Market Declines: Some Information for Investors

Oscar Health (OSCR) gained 1.76% to $32.91, outperforming a declining market. The company holds a Zacks Rank #1 (Strong Buy) with consensus EPS estimates up 79.25% year-over-year and revenue projected at $4.72 billion (+58.14% YoY). Full-year earnings are expected at $1.83 per share (+208.28%) with revenue of $18.81 billion (+60.77%). Over the last 30 days, EPS estimates have risen 18.79%, though the stock trades at a Forward P/E of 17.64, above its industry average of 9.84.